4Indexed trials
drug · Product Intelligence
Lisdexamfetamine
Pipeline Intelligence
Lisdexamfetamine: 4 indexed trials, 4 sponsors; 0 linked Orange Book patents and 5 FDA-linked events where matched.
4Sponsors
0Orange Book patent links
5FDA-linked events
Development evidence
NCT01127607Florida International University · adhdPHASE4
NCT02635035NYU Langone Health · adhdPHASE2
NCT02712996Vanderbilt University · adhdPHASE4
NCT04727476Aarhus University Hospital · adhdUNKNOWN
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALLISDEXAMFETAMINE DIMESYLATE · 2023-08-25
FDA_APPROVALLISDEXAMFETAMINE DIMESYLATE · 2023-08-25
FDA_APPROVALLISDEXAMFETAMINE DIMESYLATE · 2023-08-25
FDA_APPROVALLISDEXAMFETAMINE DIMESYLATE · 2023-08-25
FDA_APPROVALVYVANSE · 2017-01-28
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.